GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (FRA:TKDA) » Definitions » Cyclically Adjusted PB Ratio

Takeda Pharmaceutical Co (FRA:TKDA) Cyclically Adjusted PB Ratio : 1.17 (As of Jun. 10, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-06-10), Takeda Pharmaceutical Co's current share price is €12.20. Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €10.42. Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 1.17.

The historical rank and industry rank for Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:TKDA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.03   Med: 1.39   Max: 2.42
Current: 1.25

During the past years, Takeda Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 2.42. The lowest was 1.03. And the median was 1.39.

FRA:TKDA's Cyclically Adjusted PB Ratio is ranked better than
65.77% of 745 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs FRA:TKDA: 1.25

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Takeda Pharmaceutical Co's adjusted book value per share data for the three months ended in Mar. 2024 was €14.233. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €10.42 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.17 1.40 1.19 1.37 1.24

Takeda Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.37 1.40 1.41 1.21 1.24

Competitive Comparison of Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=12.20/10.42
=1.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Takeda Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=14.233/107.2000*107.2000
=14.233

Current CPI (Mar. 2024) = 107.2000.

Takeda Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 10.909 98.000 11.933
201409 11.271 98.500 12.267
201412 10.775 97.900 11.799
201503 10.435 97.900 11.426
201506 9.920 98.400 10.807
201509 9.997 98.500 10.880
201512 10.075 98.100 11.010
201603 9.888 97.900 10.827
201606 9.750 98.100 10.654
201609 10.161 98.000 11.115
201612 10.333 98.400 11.257
201703 10.044 98.100 10.976
201706 10.348 98.500 11.262
201709 10.111 98.800 10.971
201712 10.121 99.400 10.915
201803 9.776 99.200 10.564
201806 10.171 99.200 10.991
201809 10.609 99.900 11.384
201812 10.221 99.700 10.990
201903 13.269 99.700 14.267
201906 12.826 99.800 13.777
201909 13.187 100.100 14.122
201912 12.900 100.500 13.760
202003 12.744 100.300 13.621
202006 12.375 99.900 13.279
202009 11.990 99.900 12.866
202012 11.741 99.300 12.675
202103 12.785 99.900 13.719
202106 12.586 99.500 13.560
202109 13.059 100.100 13.985
202112 13.306 100.100 14.250
202203 13.951 101.100 14.793
202206 14.426 101.800 15.191
202209 15.220 103.100 15.825
202212 13.899 104.100 14.313
202303 14.281 104.400 14.664
202306 14.535 105.200 14.811
202309 14.281 106.200 14.415
202312 13.684 106.800 13.735
202403 14.233 107.200 14.233

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Takeda Pharmaceutical Co  (FRA:TKDA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co (FRA:TKDA) Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (FRA:TKDA) Headlines

No Headlines